Quality & Science

ASAM Issues Policy Statement on Patient Access to Addiction Medications

by ASAM Staff | April 30, 2013

The American Society of Addiction Medicine (ASAM) stated today that treatment decisions on the use of FDA-approved medications for addiction to opioids such as pain medicine and heroin should be made only by skilled physicians. Limits by governments and insurers on addiction medications can lead to patient relapse, crime, overdose and death.

ASAM’s Public Policy Statement on Pharmacological Therapies for Opioid Use Disorder states that evidence-based treatment for opioid use disorders should be individually tailored, and usually requires chronic disease management that includes a combination of psychotherapeutic, psychosocial and pharmacological interventions.

Read the press release here.

Read the policy statement here.